KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Short-Term Debt issuances (2016 - 2026)

Medtronic (MDT) has disclosed Short-Term Debt issuances for 13 consecutive years, with -$1.2 billion as the latest value for Q1 2026.

  • Quarterly Short-Term Debt issuances fell 22.53% to -$1.2 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.2 billion through Jan 2026, up 223.44% year-over-year, with the annual reading at $1.1 billion for FY2024, 53.02% down from the prior year.
  • Short-Term Debt issuances hit -$1.2 billion in Q1 2026 for Medtronic, down from $753.0 million in the prior quarter.
  • In the past five years, Short-Term Debt issuances ranged from a high of $2.3 billion in Q4 2022 to a low of -$1.7 billion in Q1 2023.
  • Historically, Short-Term Debt issuances has averaged $252.1 million across 5 years, with a median of $528.5 million in 2023.
  • Biggest five-year swings in Short-Term Debt issuances: plummeted 224.8% in 2024 and later surged 1598.41% in 2025.
  • Year by year, Short-Term Debt issuances stood at $2.3 billion in 2022, then tumbled by 64.05% to $821.0 million in 2023, then plummeted by 32.16% to $557.0 million in 2024, then skyrocketed by 35.19% to $753.0 million in 2025, then plummeted by 263.21% to -$1.2 billion in 2026.
  • Business Quant data shows Short-Term Debt issuances for MDT at -$1.2 billion in Q1 2026, $753.0 million in Q4 2025, and $649.0 million in Q3 2025.